NCT03673319

Brief Summary

This study will evaluate placebo mechanisms related to dry needling(DN) trying to determinate whether an additive effect occurs when DN is provided with an instructional set known to enhance placebo analgesia. External manipulation of patient expectation for receiving DN will be performed, in a similar way as has been already done in studies investigating the influence of expectation on spinal manipulative therapy interventions. The main purpose of this study will be therefore to determine, for the first time, how subjects' expectation about the effect of DN influences the resultant hypoalgesia. Analgesic effects of DN will be assessed using the conditioned pain modulation (CPM) paradigm, which has not been previously evaluated in relation to DN.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 13, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 17, 2018

Completed
17 days until next milestone

Study Start

First participant enrolled

October 4, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2019

Completed
Last Updated

August 19, 2019

Status Verified

August 1, 2019

Enrollment Period

7 months

First QC Date

September 13, 2018

Last Update Submit

August 14, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain Intensity: Visual Analog Scale (VAS)

    The investigators use a Visual Analog Scale (VAS) to determine the intensity of the patient's current pain before, during DN and immediately after DN. We will follow the paradigm of Conditioned pain modulation (CPM) paradigm. CPM will be induced by inflating an occlusion cuff (conditioning stimulus) at the arm, at the opposite side from the affected upper trapezius.The VAS is a 100-mm line, oriented horizontally, with one end representing "no pain"(the best value) and the other end representing "worst pain" (the worse value). Subjects will be asked to rate their current pain with a mark on the scale.

    Change from Baseline at after intervention

Secondary Outcomes (3)

  • Pain Pressure Threshold (PPT)

    Change up 1 hour

  • Dry needling pain

    Change up 1 hour

  • Dry needling anxiety

    Change up 1 hour

Study Arms (2)

Positive expectative

EXPERIMENTAL

Participants in the positive expectation group will be told that DN procedure: "is a very effective form of treatment used to treat neck-shoulder pain and it is expected to reduce your perception of pressure pain"

Procedure: Dry needling with positives expectation

Neutral expectatives

EXPERIMENTAL

Participants in the neutral expectation group will be told that DN procedure: "is a form of treatment used to treat neck-shoulder pain that has unknown effects on your perception of pressure pain"

Procedure: Dry needling with neutral expectation

Interventions

DN procedure: "is a very effective form of treatment used to treat neck-shoulder pain and it is expected to reduce your perception of pressure pain"

Positive expectative

DN procedure: "is a form of treatment used to treat neck-shoulder pain that has unknown effects on your perception of pressure pain"

Neutral expectatives

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • neck pain (≥3 months of duration)
  • VAS of 4-5 of pain.
  • Presence of at least one active MTrP located at the upper trapezius.

You may not qualify if:

  • Patients with previous cervical spine or shoulder surgery.
  • Cervical spine radiculopathy or myelopathy.
  • Systemic disease.
  • Fibromyalgia.
  • Pregnancy.
  • Using sedative drugs.
  • Needle phobia.
  • Bleeding disorder.
  • anticoagulant medication.
  • Previous experience with DN for myofascial pain.
  • Skin lesion and infection or inflammatory oedema at the MTrPs site

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Institut Physiotherapy AND pain

Alcalá de Henares, Madrid, 28805, Spain

Location

Grupo Fisioterapia y Dolor

Alcalá de Henares, Madrid, 28871, Spain

Location

MeSH Terms

Conditions

Neck Pain

Interventions

Dry Needling

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsPhysical Therapy Modalities

Study Officials

  • Daniel Pecos-Martin, Phd

    Alcala University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 13, 2018

First Posted

September 17, 2018

Study Start

October 4, 2018

Primary Completion

April 30, 2019

Study Completion

July 31, 2019

Last Updated

August 19, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

The IDP does not exist

Locations